ReviewFrontiers in immunology2021

Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.

Zhiheng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.